Page last updated: 2024-10-24

chlorambucil and Carcinoma, Ovarian Epithelial

chlorambucil has been researched along with Carcinoma, Ovarian Epithelial in 1 studies

Chlorambucil: A nitrogen mustard alkylating agent used as antineoplastic for chronic lymphocytic leukemia, Hodgkin's disease, and others. Although it is less toxic than most other nitrogen mustards, it has been listed as a known carcinogen in the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (Merck Index, 11th ed)
chlorambucil : A monocarboxylic acid that is butanoic acid substituted at position 4 by a 4-[bis(2-chloroethyl)amino]phenyl group. A chemotherapy drug that can be used in combination with the antibody obinutuzumab for the treatment of chronic lymphocytic leukemia.

Carcinoma, Ovarian Epithelial: A malignant neoplasm that originates in cells on the surface EPITHELIUM of the ovary and is the most common form of ovarian cancer. There are five histologic subtypes: papillary serous, endometrioid, mucinous, clear cell, and transitional cell. Mutations in BRCA1, OPCML, PRKN, PIK3CA, AKT1, CTNNB1, RRAS2, and CDH1 genes are associated with this cancer.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
WILTSHAW, E1

Other Studies

1 other study available for chlorambucil and Carcinoma, Ovarian Epithelial

ArticleYear
A RETROSPECTIVE COMPARISON OF CHLORAMBUCIL AND RADIOTHERAPY IN THE TREATMENT OF OVARIAN ADENOCARCINOMA.
    The Journal of obstetrics and gynaecology of the British Commonwealth, 1965, Volume: 72

    Topics: Adenocarcinoma; Carcinoma, Ovarian Epithelial; Chlorambucil; Drug Therapy; Female; Humans; Neoplasms

1965